Insilico Medicine
Biotechnology company that uses artificial intelligence to develop new drugs and for aging research
Visit website: https://insilico.com/
Details last updated 09-Apr-2019
Insilico Medicine is also referenced in the following:
ARDD 2021 - 8th Aging Research and Drug Discovery Meeting
31-Aug-2021 to 03-Sep-2021
Online event about latest progress in the molecular, cellular and organismal basis of aging organized by University of Copenhagen chaired by Morten Scheibye-Knudsen, Daniela Bakula and Alex Zhavoronkov, and with many speakers.
Deep Longevity
AI to track the rate of ageing at the molecular, cellular, tissue, organ, system, physiological, and psychological levels
People at Insilico Medicine
Alex Zhavoronkov
CEO of InSilico Medicine & Deep Longevity. CSO of Biogerontology Research Foundation
Polina Mamoshina
Chief Scientist and Chief Operating Officer at Deep Longevity and Head of Biomarker Development at Insilico Medicine.
Insilico Medicine News
Insilico Medicine showcases 10 years of AI success in drug discovery
GEN - 01-Aug-2024
AI could cut preclinical drug development time by half, but rigorous trials are crucial
Read more...Insilico reveals process for manufacturing AI-generated lung disease treatment
Chemical & Engineering News (C&EN) - 10-Mar-2024
AI streamlines drug discovery, taking a potential treatment from concept to clinical trials in record time
Read more...AI and quantum computing join forces to crack the code of life
EurekAlert! - 26-Jan-2024
This "physics-guided AI" approach promises deeper insights than current methods
Read more...Researchers used artificial intelligence to treat cancer and ageing
Drug Discovery World (DDW) - 16-Nov-2023
KDM1A emerged as dual-action therapeutic target for both
Read more...SRW and Insilico partner to develop AI-powered nutraceuticals
Longevity Technology - 08-Nov-2023
Using AI to screen natural compounds and create novel longevity products
Read more...Insilico Medicine identifies potential targets for ageing and disease using AI
EurekAlert! - 27-Sep-2023
Highlights the potential of AI to accelerate drug discovery for several diseases
Read more...Insilico Medicine begins phase II trials for AI-generated drug candidate in IPF Treatment
Genetic Engineering & Biotechnology News (GEN) - 27-Jun-2023
Could target the treatment of a broader range of fibrotic indications beyond idiopathic pulmonary fibrosis
Read more...BBC reports on two different uses of AI in pharmaceutical healthcare
BBC - 17-Apr-2023
Genetika+ tests drugs against a patient's own cells; Insilico Medicine is slashing the time taken for drug discovery
Read more...Insilico Medicine series D funding to grow its pipeline and create an AI-driven robotic drug discovery laboratory
Longevity Technology - 06-Jun-2022
Big data combined with laboratory automation - the pace of drug discovery is about to take off!
Read more...Insilico raises $255M to advance human trials and AI drug discovery platform
Longevity Technology - 22-Jun-2021
New collab with Teva Pharmaceuticals to identify drug targets for various diseases
Read more...First-ever AI designed drug candidate for pulmonary fibrosis
Longevity Technology - 24-Feb-2021
Insilico's novel drug target is prepping for IND studies, expecting to start clinical studies by early 2022
Read more...Super summary of 3rd Annual Longevity Therapeutics Summit
Lifespan.io (LEAF) - 16-Feb-2021
More and more companies making greater and greater progress - 2021 could be an exciting year
Read more...Pharma company teams with AI to develop anti aging solutions
Longevity Technology - 15-Oct-2020
Taisho and Insilico collabs to identify novel targets for senolytic drugs
Read more...AI reduces drug discovery from years to days - and that's just the start
Singularity Hub - 23-Jul-2020
Insilico Medicine is slashing the cost of drug development
Read more...Deep Longevity investors bet on growing need for aging and longevity biomarkers
FierceBiotech - 15-Jul-2020
Biological clocks are a moving target so they'll need other researchers to corroborate their analysis
Read more...Is it possible to predict biological age with gut microbiome?
Lifespan.io (LEAF) - 19-Jun-2020
Models and anti-ageing intervention design enables new ageing clock development
Read more...Orion College ageing research receives 1 million UK pounds from Jim Mellon
Lifespan.io (LEAF) - 18-May-2020
He believes in the importance of boosting immunoresilience among elderly
Read more...Proposed strategy to protect elderly from gerolavic infections like COVID-19
Forbes - 31-Mar-2020
To benefit long term global health and longevity, and enhance economic recovery
Read more...Clinical trials now up for Exscientia's world first AI-made drug
pharmaphorum - 30-Jan-2020
Partnering with Japan's DSP, a milestone is reached in OCD treatment
Read more...Nanalyze looks at Insilico Medicine's AlphaGo moment in pharma
Nanalyze - 09-Oct-2019
From lab to clinic in 2 years instead of 10 would have a huge impact on health
Read more...Display all news
